CN100353166C - Enzyme tag stabilizing agent - Google Patents

Enzyme tag stabilizing agent Download PDF

Info

Publication number
CN100353166C
CN100353166C CNB200410057389XA CN200410057389A CN100353166C CN 100353166 C CN100353166 C CN 100353166C CN B200410057389X A CNB200410057389X A CN B200410057389XA CN 200410057389 A CN200410057389 A CN 200410057389A CN 100353166 C CN100353166 C CN 100353166C
Authority
CN
China
Prior art keywords
stabilizing agent
enzyme labeling
labeling thing
enzyme
bsa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB200410057389XA
Other languages
Chinese (zh)
Other versions
CN1743846A (en
Inventor
杨晓林
孙旭东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yuande Biological Medicine Engineering Co Ltd Beijing
Original Assignee
Yuande Biological Medicine Engineering Co Ltd Beijing
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuande Biological Medicine Engineering Co Ltd Beijing filed Critical Yuande Biological Medicine Engineering Co Ltd Beijing
Priority to CNB200410057389XA priority Critical patent/CN100353166C/en
Publication of CN1743846A publication Critical patent/CN1743846A/en
Application granted granted Critical
Publication of CN100353166C publication Critical patent/CN100353166C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to a novel stabilizing agent of enzyme markers for prolonging the preservation time of the solutions of the enzyme markers, which belongs to immunoassay products capable of using the enzymic markers as tracer agents. The stabilizing agent is prepared from protein, haemoglobin, anti-free radical substances and buffer solutions and can be widely used in a plurality of departments, comprising clinical diagnosis, scientific research, environment and sanitary detection, medicolegal expertise, etc.

Description

Novel enzyme label stabilizing agent
Technical field
The present invention is a kind of can be used for in the immune detection product of enzyme labeling thing as tracer agent, to prolong the novel enzyme label stabilizing agent of enzyme labeling thing solution storage life.
Background technology
The immune detection analytical technology has obtained using widely in current biomedical sector, and detected in clinical diagnosis, scientific research, environment and health, legal medical expert identifies etc. allly becomes indispensable routine techniques means in multidisciplinary, bringing into play irreplaceable effect, therefore relevant testing product also just has huge market.Present detection technique mostly all with the enzyme labeling thing as tracer agent, and wherein common with the connection thing of peroxidase.Because the main biochemical activity of this enzyme is to change the superoxide in the reaction system into superoxide radical, therefore this enzyme labeling thing also can will exist in its solution, perhaps the small amounts material that produces gradually in storing, transporting is converted into superoxide radical, the latter then can attack consumingly enzyme molecule itself and with its bioactive molecule that connects mutually, thereby cause its inactivation.Because this " suicide " phenomenon usually causes the enzyme labeling thing to take the lead in losing efficacy, so the stability of enzyme labeling thing has also just become to improve the bottleneck of such detectable product reliability and the term of validity.Therefore many products are forced to use freeze-drying or concentrate the enzyme labeling thing of refrigeration, but this needs the user by the way of redissolving or diluting preparation work liquid voluntarily, this has not only increased user's workload, and also can cause new operate miss certainly, also be not suitable for the matched reagent of robotization detecting instrument simultaneously.
In recent years, can in enzyme labeling thing solution, consume superoxide radical or the stable thing molecule that connects owing to it is found that some, do not influence simultaneously the material of immune response and enzyme-substrate reactions again, as: some possesses vitamin, some Polyphenols or polyhydroxy class material, some polyamino acid etc. of anti-oxidation characteristics, thereby prolonged the storage life of enzyme labeling thing solution greatly, lay a good foundation for such testing product directly adopts the enzyme labeling thing working fluid of room temperature preservation, these materials are called as label stabilizing agent (Conjugator Stabilizer).In fact, the enzyme labeling thing that contains stabilizing agent working fluid can directly be provided, with the room temperature preservation that realizes product and the high reliability that guarantees this detectable and the long term of validity, the technology content of this series products and the important symbol of manufacturer's research and development ability and level have been become to weigh at present.
Summary of the invention
How to find and use to have on Green Tea Extract or the stable particular matter that connects the thing molecular characterization but the notice of past people mainly concentrates on, and ignored the possibility of eliminating enzyme labeling thing " suicide " phenomenon by other approach.We find that through years of researches and practice two kinds of common reagent are arranged, and promptly albumen (as BSA) and haemoglobin (HB) can delay the deactivation phenomenom of enzyme labeling thing effectively under some particular concentration condition.
Wherein because high concentration BSA can reduce the nonspecific immunity reaction greatly, therefore be present the most frequently used sealer, extensively made an addition in all kinds of immunologic function test reagents, its working concentration is all more than 1%, and in order further to reduce non-specific responding, often use the BSA of higher concentration, for example about 3% to 5%.And we find that BSA has two-phase for the generation and the consumption of free radical, i.e. its attack that both can replace the enzyme labeling thing to bear free radical, thereby as a kind of free radical scavengers for protecting enzyme labeling thing; Can in the process of self degrading, discharge peroxidating material and even free radical again simultaneously, thereby quicken the inactivation of enzyme labeling thing, therefore select suitable BSA concentration extremely important for protective enzyme label activity.We are by a large amount of experiment confirms: BSA concentration is relatively stable on a reduced levels in the active decline rate of 1% enzyme labeling thing when following; And active decline rate increases suddenly when this concentration is above, and as active decline rate doubled by 3% o'clock, active decline rate increased more than ten times by 10% o'clock.Simultaneously, the experiment of using all kinds of other albumen to replace BSA to carry out all demonstrates similar result, illustrates that this effect and albumen kind are irrelevant, and only closely related with its concentration.Take all factors into consideration the requirement that suppresses non-specific responding and protective enzyme label activity, the optium concentration of each albuminoid of experiment confirm in enzyme labeling thing solution is all between 0.1% to 1%.
And, be considered to cause the interfering material of non-special signal simultaneously because HB usually is present among the commercial rough BSA, therefore make every effort to for a long time it is removed from the related immune detectable always.As everyone knows, because HB has the iron porphyrin of containing, therefore have stronger free radical catalytic activity, promptly react the conversion that causes between superoxide radical and the hydroxyl radical free radical, so we think that its tool in the Green Tea Extract process has certain effect by FantonShi reaction and HaberweissShi.Specifically, by above-mentioned reaction the superoxide radical of longer life is converted to more short-life hydroxyl radical free radical exactly, and the latter is consumed very soon by attacking HB self or near molecule, under all lower situation of HB and enzyme labeling substrate concentration, near the probability of the enzyme labeling thing molecule HB molecule is very little, and therefore the possibility of being attacked is also little; Because above-mentioned reaction has reduced the superoxide radical concentration of longer life, attack the possibility of enzyme labeling thing molecule simultaneously thereby further reduced it.We confirm by experiment: the active decline rate of HB concentration enzyme labeling thing when 50 μ g/ml to 200 μ g/ml reduces about 50% than not adding HB, its non-specific responding of while also a little less than; And more than 200 μ g/ml or 50 μ g/ml DeGrain when following, and, HB concentration strengthens rapidly along with increasing non-specific responding.Take all factors into consideration the requirement that suppresses non-specific responding and protective enzyme label activity, we think that the optium concentration of HB in enzyme labeling thing solution should be between 50 μ g/ml to 200 μ g/ml.
In sum, we think that above-mentioned two class materials are under specific concentrations, the label stabilizing effect is obvious for improving, and have the advantages that cost is low, be easy to prepare, can be widely used in in the immune detection product of enzyme labeling thing as tracer agent, thus the storage life that has prolonged enzyme labeling thing solution greatly.Therefore it is all multidisciplinary to be widely used in clinical diagnosis, scientific research, environment and health detection, legal medical expert's evaluation etc.
Embodiment
Below be an embodiment of this invention, this embodiment only is used to illustrate the present invention, but content of the present invention is not limited to following examples.
In the phosphoric acid isotonic buffer solution (PBS) of pH7.2, add the 5mMol/L vitamin C as antioxidant, add 3% or 0.5% BSA simultaneously respectively, and the HB of 50 μ g/ml is as enzyme labeling thing stabilizing agent.After horseradish peroxidase (HRP) that adds dilution in 1: 1000 and anti-prostate specific antigen (PSA) antibody connect thing, place 37 ℃ of water-baths to carry out hot accelerated tests whole solution, to verify its effect.The enzyme labeling thing activity in the above-mentioned solution is measured in the back all around, and the activity of its result before by accelerated tests is 100%, calculates respectively that respectively to organize residual activity as follows:
Stabilizer type residual activity (100%)
(1)3%BSA 26.7
(2)0.5%BSA 51.2
(3)0.5%BSA+50μg/mlHB 97.6

Claims (3)

1. an enzyme labeling thing stabilizing agent is made up of bovine serum albumin(BSA), haemoglobin, antioxidant and damping fluid; It is characterized in that: it is 0.1% to 1% bovine serum albumin(BSA) and the concentration haemoglobin as 50-200 μ g/ml that this stabilizing agent has used concentration.
2. according to the enzyme labeling thing stabilizing agent of claim 1, wherein said antioxidant is vitamin, polyphenols, polyhydroxy class material or the polyamino acid that possesses anti-oxidation characteristics.
3. according to the enzyme labeling thing stabilizing agent of claim 1, wherein said antioxidant is a vitamin C.
CNB200410057389XA 2004-08-30 2004-08-30 Enzyme tag stabilizing agent Expired - Fee Related CN100353166C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB200410057389XA CN100353166C (en) 2004-08-30 2004-08-30 Enzyme tag stabilizing agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB200410057389XA CN100353166C (en) 2004-08-30 2004-08-30 Enzyme tag stabilizing agent

Publications (2)

Publication Number Publication Date
CN1743846A CN1743846A (en) 2006-03-08
CN100353166C true CN100353166C (en) 2007-12-05

Family

ID=36139306

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB200410057389XA Expired - Fee Related CN100353166C (en) 2004-08-30 2004-08-30 Enzyme tag stabilizing agent

Country Status (1)

Country Link
CN (1) CN100353166C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8476050B2 (en) 2010-06-04 2013-07-02 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Conjugate preparation methods and related kit
US8753858B2 (en) 2009-12-31 2014-06-17 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Reagents and processes for stabilizing alkaline phosphatase or conjugates thereof
US8940512B2 (en) 2010-06-04 2015-01-27 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Processes for synthesizing alkaline phosphatase conjugates

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102866248A (en) * 2012-09-28 2013-01-09 北京鸿天志远科技有限公司 Stabilizer solution and preparation method thereof, enzyme conjugate mixture and protein mixture
CN107037207B (en) * 2017-06-20 2018-08-24 山东莱博生物科技有限公司 A kind of c-hepatitis antibody polymer enzyme marker and its preparation and application

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07289258A (en) * 1994-04-27 1995-11-07 Meiji Milk Prod Co Ltd Method for stabilizing peroxidase in solution
CN1428436A (en) * 2001-12-27 2003-07-09 张抗 Digestive system tumor diagnosis kit
CN1500884A (en) * 2002-11-15 2004-06-02 江西特康科技有限公司 Nicotinamide agent and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07289258A (en) * 1994-04-27 1995-11-07 Meiji Milk Prod Co Ltd Method for stabilizing peroxidase in solution
CN1428436A (en) * 2001-12-27 2003-07-09 张抗 Digestive system tumor diagnosis kit
CN1500884A (en) * 2002-11-15 2004-06-02 江西特康科技有限公司 Nicotinamide agent and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"自由基与抗自由基药物之临床应用" 张季平.当代医学,第23卷第12期 1996 *
"酶稳定剂和还原剂对固定化葡萄糖氧化酶稳定性的影响" 李丽霞,俞耀庭,鲁格.生物工程学报,第3卷第3期 1987 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8753858B2 (en) 2009-12-31 2014-06-17 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Reagents and processes for stabilizing alkaline phosphatase or conjugates thereof
US8476050B2 (en) 2010-06-04 2013-07-02 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Conjugate preparation methods and related kit
US8940512B2 (en) 2010-06-04 2015-01-27 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Processes for synthesizing alkaline phosphatase conjugates

Also Published As

Publication number Publication date
CN1743846A (en) 2006-03-08

Similar Documents

Publication Publication Date Title
Townson et al. Characterisation and purification of pyruvate: ferredoxin oxidoreductase from Giardia duodenalis
CN102154443B (en) Creatine jubase MB isozyme activity detection reagent and preparation method thereof
Guarise et al. Gold nanoparticles-based protease assay
Jiang et al. New class of small nonpeptidyl compounds blocks Plasmodium falciparum development in vitro by inhibiting plasmepsins
Achstetter et al. Proteolysis in eukaryotic cells. Identification of multiple proteolytic enzymes in yeast.
Watanabe et al. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation
Harpel Plasmin inhibitor interactions. The effectiveness of alpha2-plasmin inhibitor in the presence of alpha2-macroglobulin.
JP5222331B2 (en) Sample pretreatment method for measuring glycated amine and method for measuring glycated amine
WO2002006519A1 (en) Method of selectively determining glycated hemoglobin
CN100353166C (en) Enzyme tag stabilizing agent
CN102072953A (en) Method and kit for stably detecting sialic acid by enzyme method
Stürzebecher et al. Dramatic enhancement of the catalytic activity of coagulation factor IXa by alcohols
CN102866248A (en) Stabilizer solution and preparation method thereof, enzyme conjugate mixture and protein mixture
Raya-Sánchez et al. Coagulation inhibitors in alcoholic liver cirrhosis
El‐Shanshory et al. Asymmetric dimethylarginine levels in children with sickle cell disease and its correlation to tricuspid regurgitant jet velocity
CN104388530B (en) The lactate detection reagent that a kind of stability is strong
Kwon et al. Rapid determination of blood coagulation factor XIII activity using protein arrays for serodiagnosis of human plasma
Bauer et al. Arterial versus venous metabolism of nitroglycerin to nitric oxide: a possible explanation of organic nitrate venoselectivity
Crawford et al. Evidence that a quinone may be required for the production of superoxide and hydrogen peroxide in neutrophils
Thorn Activation of succinate dehydrogenase in heart-muscle preparations
Grdisa et al. Types and localization of aminopeptidases in different human blood cells.
CN102564979A (en) Method for determining alcohol concentration by using enzyme cycling method and alcohol determination kit
Fabrini et al. Spectrophotometric assay for serum glutathione transferase: a re-examination
Frey et al. Binding of acetyl-CoA to chicken liver pyruvate carboxylase.
Zeitlin et al. The molecular weights of plasma and intestinal kallikreins in rats.

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20071205

Termination date: 20190830

CF01 Termination of patent right due to non-payment of annual fee